- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05087407
Decompression and Drainage Seton in the Treatment of High Complex Anal Fistula
October 22, 2021 updated by: Hui Li, China-Japan Friendship Hospital
Cutting Seton Versus Decompression and Drainage Seton in the Treatment of High Complex Anal Fistula
This study aimed to compare the efficacy of the decompression and drainage seton (DADS) and cutting seton (CS) in the treatment of high complex anal fistula.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100029
- China-Japan Friendship Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years to 60 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- high trans-sphincteric cryptoglandular anal fistulas (involving >30% of the EAS muscles evaluated through magnetic resonance imaging (MRI) scan, endoanal ultrasonography)
- suprasphincteric fistulas were enrolled
Exclusion Criteria:
- Low anal fistula; -Non-glandular anal fistulas, such as tuberculous anal fistula and Crohn's anal fistula; -
- Patients with symptoms of fecal incontinence;
- A previous history of anal fistula surgical treatment;
- Patients with malignant tumors or mental illness or other reasons unable to cooperate with the treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: decomprssion and drainage seton
|
Incision the internal sphincter over the fistula tract in intersphinteric space to achieve decompression then drainage seton will be put around external sphincter.
|
ACTIVE_COMPARATOR: Cutting seton
|
Cutting seton is introduced from outside openning to internal openning and encircling the internal and external anal sphincter.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of healing
Time Frame: 6 months post-operation.
|
complete healing was defined as complete epithelialization of the wound, with no evidence of external fistula opening or perianal discharge under physical examination.
|
6 months post-operation.
|
Recurrence rate
Time Frame: within 12 months after the procedure
|
recurrence was defined as the clinical reappearance of the fistula after complete healing, removal or fall-off of seton
|
within 12 months after the procedure
|
The healing time of the anal wound (days)
Time Frame: 6 months post-operation.
|
the time needed to achieve complete healing of anal fistula.
|
6 months post-operation.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 1, 2016
Primary Completion (ACTUAL)
December 1, 2019
Study Completion (ACTUAL)
May 1, 2020
Study Registration Dates
First Submitted
October 12, 2021
First Submitted That Met QC Criteria
October 20, 2021
First Posted (ACTUAL)
October 21, 2021
Study Record Updates
Last Update Posted (ACTUAL)
October 28, 2021
Last Update Submitted That Met QC Criteria
October 22, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- No.2016-81
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on High Complex Anal Fistula
-
F Care Systems NVNot yet recruiting
-
Dr Benjamin NEBBOTSuspended
-
Groupe Hospitalier Paris Saint JosephCompletedComplex Anal FistulaFrance
-
University Hospital, Clermont-FerrandUnknown
-
Chinese University of Hong KongTerminated
-
Assiut UniversityActive, not recruiting
-
University Hospital, Basel, SwitzerlandUnity Health Toronto; Mount Sinai Hospital, Canada; Women's College Hospital; St...CompletedComplex Anal FistulaSwitzerland
-
Zagazig UniversityCompletedTranssphincteric Anal FistulaEgypt
-
Societa Italiana di Chirurgia ColoRettaleTerminated
-
Mansoura UniversityUnknownVideo Assisted Anal Fistula TreatmentEgypt
Clinical Trials on Cutting seton
-
China-Japan Friendship HospitalRecruiting
-
Assiut UniversityActive, not recruiting
-
Friedrich-Alexander-Universität Erlangen-NürnbergRecruiting
-
Societa Italiana di Chirurgia ColoRettaleTerminated
-
Services Hospital, LahoreCompletedPerianal FistulaPakistan
-
Mansoura UniversityCompleted
-
Mansoura UniversityUnknown
-
Avobis Bio, LLCAlimentiv Inc.RecruitingCrohn's Disease | Perianal FistulaUnited States